In light of these findings, it is possible that GRP94 downregulation in NASH tissues (Figure 2) is involved in dysfunctional lipid metabolism as well as NASH-related proliferative diseases. This evidence concerns the gene HSP90B1 and metabolic dysfunction-associated steatohepatitis.